A Phase 2, Randomized, Double-Blind, Placebo-Controlled

Project: Research project

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Enzalutamide in Subjects with Advanced Hepatocellular Carcinoma
StatusActive
Effective start/end date2/1/162/28/21

Funding

  • ASTELLAS PHARMA, INC.

Fingerprint

Hepatocellular Carcinoma
Placebos
Safety
MDV 3100